AH
Ankurkumar Hasmukhbhai Patel
About Ankurkumar Hasmukhbhai Patel
Data last updated:
Ankurkumar Hasmukhbhai Patel is an Additional Director at Trilend Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Trilend Pharmaceuticals Private Limited reported revenue of ₹2.24 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 12 May 2025 | 2019 | ₹2.24 Cr (FY 2024) | Active |
Board colleagues of Ankurkumar Hasmukhbhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alpeshkumar Kantilal Patel | 08401937 | Trilend Pharmaceuticals Private Limited | Director |
| Nitin Jasvantbhai Patel | 05225550 | Trilend Pharmaceuticals Private Limited | Additional Director |
| Pareshbhai Hirabhai Patel | 08402044 | Trilend Pharmaceuticals Private Limited | Director |
| Suhas Ishvarlal Patel | 10255172 | Trilend Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankurkumar Hasmukhbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankurkumar Hasmukhbhai Patel
Ankurkumar Hasmukhbhai Patel currently holds 1 directorship: Trilend Pharmaceuticals Private Limited (Additional Director, since 12 May 2025, revenue ₹2.24 Cr (FY 2024)).
Ankurkumar Hasmukhbhai Patel was first appointed on 12 May 2025 as Additional Director at Trilend Pharmaceuticals Private Limited.
The current boards of Ankurkumar Hasmukhbhai Patel's companies include Alpeshkumar Kantilal Patel (Trilend Pharmaceuticals Private Limited), Nitin Jasvantbhai Patel (Trilend Pharmaceuticals Private Limited), Pareshbhai Hirabhai Patel (Trilend Pharmaceuticals Private Limited), Suhas Ishvarlal Patel (Trilend Pharmaceuticals Private Limited).